Ipamorelin is a selective growth hormone secretagogue and a pentapeptide that mimics the body’s natural growth hormone-releasing hormone (GHRH). It specifically stimulates the pituitary gland to release growth hormone (GH) without significantly affecting cortisol, prolactin, or other hormones. Ipamorelin is valued for its potent GH-releasing effects combined with a favorable safety profile, making it a popular choice in anti-aging, athletic performance, and therapeutic contexts.
Development: Ipamorelin was developed as a synthetic analog to GHRH, designed to stimulate GH release effectively while minimizing side effects commonly associated with other growth hormone secretagogues (GHS) like GHRP-6 and GHRP-2.
Research and Applications: Initially studied for its potential in enhancing growth hormone levels with fewer side effects, Ipamorelin has gained popularity for its ability to support muscle growth, fat loss, recovery, and general well-being. It is widely used in anti-aging and athletic settings.